IP Library Granted Patent US 10,835,747
Granted Patent B2
US 10,835,747 · App. 16/581,139 · Granted Nov 17, 2020

Auricular nerve stimulation to address patient disorders, and associated systems and methods

Inventors: Vivek K. Sharma (San Ramon, CA); Konstantinos Alataris (Menlo Park, CA); Gary Heit (Redwood City, CA); Jason Sutor (Pacific Grove, CA); Pankaj Sunkeri (Belmont, CA)
Assignee: Vorso Corp.
A61N1/36034A61N1/0456A61N1/36021A61N1/36025A61N1/36036
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,835,747
App. No.
16/581,139
Granted
Nov 17, 2020
Kind
B2
Abstract

Auricular nerve stimulation techniques for addressing patient disorders, and associated systems and methods. A representative system includes a signal generator having instructions to generate an electrical therapy signal, at least a portion of the electrical therapy signal having a frequency at or above the patient's auditory frequency limit, an amplitude in an amplitude range from about 0.1 mA to about 10 mA, and a pulse width in a pulse width range from 5 microseconds to 30 microseconds. The system further includes at least one earpiece having a contoured outer surface shaped to fit against the skin of the patient's external ear, external ear canal, or both, the at least one earpiece carrying at least two transcutaneous electrodes positioned to be in electrical communication with the auricular innervation of the patient, e.g., the auricular vagal nerve.

Claims (66)

1. A system for treating a patient having a post-partum depression, comprising:

a signal generator having instructions to generate an electrical therapy signal to treat the patient's post-partum depression, at least a portion of the electrical therapy signal having:

a frequency at or above the patient's auditory frequency limit, wherein the frequency is in a frequency range of about 15 kHz to about 50 kHz;

an amplitude in an amplitude range from about 0.1 mA to about 10 mA; and

a pulse width in a pulse width range from 5 microseconds to 30 microseconds; and

at least one earpiece having a contoured outer surface shaped to fit against the skin of the patient's external ear, external ear canal, or both, the at least one earpiece carrying at least two transcutaneous electrodes coupled to the signal generator and positioned to be in electrical communication with an auricular nerve of the patient.

2. The system of claim 1 wherein the electrical therapy signal is a non-paresthesia-generating electrical therapy signal.

3. The system of claim 1 wherein the electrical therapy signal is a non-sensory response electrical therapy signal.

4. The system of claim 1 wherein the at least two transcutaneous electrodes include a conductive polymer outer surface.

5. The system of claim 1 wherein the signal generator includes a neckpiece positionable to be supported by the patient around the patient's neck, and wherein the system further comprises an earpiece link coupled between the neckpiece and the at least one earpiece.

6. The system of claim 5 wherein the earpiece link includes at least one elongated conductor.

7. The system of claim 5 wherein the at least one earpiece is removable from the earpiece link.

8. The system of claim 5 wherein the earpiece link and the signal generator are contained in a unitary housing.

9. The system of claim 1 wherein the at least one earpiece includes a first earpiece shaped to fit the patient's right ear and a second earpiece shaped to fit the patient's left ear.

10. The system of claim 1 wherein the at least one earpiece is custom fit to the patient's ear.

11. The system of claim 1 , further comprising an audible feedback device coupled to the at least one earpiece to generate a feedback signal in the patient's audible frequency range.

12. The system of claim 11 wherein a frequency of the feedback signal is patient-specific.

13. The system of claim 1 , further comprising a proximity sensor positioned to detect a location of the at least one of the electrodes relative to the patient's skin.

14. The system of claim 1 , further comprising an external controller configured to be in wireless communication with the signal generator.

15. The system of claim 14 wherein the external controller includes a mobile device having an application for controlling the signal generator.

16. A system for treating a patient having post-partum depression, comprising:

a signal generator having instructions to generate an electrical therapy signal to treat the patient's post-partum depression, at least a portion of the electrical therapy signal having:

an average frequency at or above the patient's auditory frequency limit, wherein the average frequency is in a frequency range of about 15 kHz to about 50 kHz, wherein the average frequency is the inverse of the average period of the signal over multiple periods, and wherein individual periods are the sum of a first pulse width of a first pulse at a first polarity, neighboring, second pulse at a second polarity opposite the first polarity, an interphase period between the first and second pulses, and an interpulse period between the second pulse and the next pulse of the first polarity;

an amplitude in an amplitude range from 0.1 mA to 10 mA; and

a pulse width in a pulse width range from 5 microseconds to 30 microseconds; and

at least one earpiece having a contoured outer surface shaped to fit against the skin of the patient's external ear, external ear canal, or both, the at least one earpiece carrying at least two transcutaneous electrodes coupled to the signal generator and positioned to be in electrical communication with an auricular nerve of the patient.

17. The system of claim 16 wherein the electrical therapy signal is a non-paresthesia-generating electrical therapy signal.

18. The system of claim 16 wherein the electrical therapy signal is a non-sensory response electrical therapy signal.

19. The system of claim 16 wherein the signal generator includes a neckpiece positionable to be supported by the patient around the patient's neck, and wherein the system further comprises an earpiece link coupled between the neckpiece and the at least one earpiece.

20. The system of claim 19 wherein the earpiece link includes at least one elongated conductor.

21. The system of claim 19 wherein the at least one earpiece is removable from the earpiece link.

22. The system of claim 16 wherein the interphase period is within a range from about 1 microsecond to about 10 microseconds.

23. The system of claim 16 wherein the interpulse period is within a range from about 1 microsecond to about 10 microseconds.

24. A method for treating a patient having post-partum depression, comprising:

applying an electrical therapy signal to an auricular nerve of the patient to treat the patient's post-partum depression, wherein the electrical therapy signal is applied via a plurality of transcutaneous electrodes carried by an earpiece positioned against the skin of the patient's external ear, external ear canal, or both; and

wherein at least a portion of the electrical therapy signal has:

a frequency at or above the patient's auditory frequency limit, wherein the frequency is in a frequency range from about 15 kHz to about 50 kHz;

an amplitude in an amplitude range from 0.1 mA to 10 mA; and

a pulse width in a pulse width range from 5 microseconds to 30 microseconds.

25. The method of claim 24 wherein the electrical therapy signal does not generate paresthesia in the patient.

26. The method of claim 24 wherein the electrical therapy signal does not generate a patient-detectable sensory response.

27. The method of claim 24 wherein applying the electrical therapy signal causes the auricular branch of the patient's vagal nerve to generate an afferent response.

28. The method of claim 24 wherein applying an electrical therapy signal includes applying the electrical therapy signal to only one of the patient's ears.

29. The method of claim 24 wherein applying an electrical therapy signal includes applying at least one electrical therapy signal to both of the patient's ears.

30. The method of claim 29 wherein the same electrical therapy signal is applied to both ears.

31. The method of claim 29 wherein applying the at least on electrical therapy signal includes applying a first electrical therapy signal to one of the patient's ears and a second electrical therapy signal to the other of the patient's ears, the first electrical therapy signal having a different parameter value than the second electrical therapy signal.

32. The method of claim 31 wherein the different parameter value includes one or more of frequency or amplitude.

33. The method of claim 29 wherein one or more electrical signals are applied to both ears simultaneously.

34. The method of claim 29 wherein one or more electrical signals are applied to both ears sequentially.

35. The method of claim 24 wherein applying the electrical therapy signal causes improved connectivity between at least two regions of the patient's brain.

36. The method of claim 24 wherein applying the electrical therapy signal includes increasing the amplitude of the electrical therapy signal over multiple steps from a first value to a second value.

37. The method of claim 24 wherein applying the electrical therapy signal is performed as part of a treatment regimen that also includes a pharmacological treatment of the patient.

38. The method of claim 24 wherein applying the electrical therapy signal includes applying the electrical therapy signal over the course of at most two sessions per day.

39. The method of claim 38 wherein an individual session lasts for between two seconds and 60 minutes.

40. The method of claim 38 wherein an individual session lasts for between two seconds and 30 minutes.

41. The method of claim 38 wherein an individual session lasts for 15 minutes.

42. The method of claim 38 , further comprising tracking a number of sessions.

43. The method of claim 24 wherein the auricular nerve includes an auricular branch of the patient's vagal nerve.

44. A method for making a patient treatment device, comprising:

programming a signal generator to produce an electrical therapy signal to treat post-partum depression, at least a portion of the electrical therapy signal having:

a frequency at or above a patient's auditory threshold, wherein the frequency is in a frequency range from about 15 kHz to about 50 kHz;

an amplitude in an amplitude range from about 0.1 mA to about 10 mA; and

a pulse width in a pulse width range from about 5 microseconds to about 30 microseconds; and

coupling the signal generator to at least one earpiece having a contoured outer surface shaped to fit against the skin of the patient's external ear, external ear canal, or both, the at least one earpiece carrying at least two transcutaneous electrodes positioned to be in electrical communication with an auricular nerve of the patient.

45. The method of claim 44 , further comprising forming the contoured outer surface of the at least one earpiece based at least in part on a patient-specific physiologic feature of the patient's ear.

46. The method of claim 44 , further comprising forming at least part of the at least one earpiece using an additive manufacturing technique.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: NESOS CORP.
To: NESOS LLC
Reel/Frame 061226/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: NESOS LLC
To: NEXTSENSE, INC.
Reel/Frame 061226/0401 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY TYPE TO BE CHANGED FROM "APPLICATION NUMBERS" 10806928 AND 10835747 TO "PATENT NUMBERS" 10806928 AND 10835747. PREVIOUSLY RECORDED ON REEL 055253 FRAME 0518. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Jan 12, 2022
From: VORSO CORP.
To: NESOS CORP.
Reel/Frame 058706/0234 →
CHANGE OF NAME Recorded Feb 8, 2021
From: VORSO CORP.
To: NESOS CORP.
Reel/Frame 055253/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: SHARMA, VIVEK K.; ALATARIS, KONSTANTINOS; HEIT, GARY; SUTOR, JASON; SUNKERI, PANKAJ
To: VORSO CORP.
Reel/Frame 053666/0180 →
Continuity (4)
Provisional Application 62891203 · Aug 23, 2019
Provisional Application 62785205 · Dec 26, 2018
Provisional Application 62735492 · Sep 24, 2018
Related Publication 20200094054A1 · Mar 26, 2020
Cited By (1)
US 12,186,557